BVF as of June 30, 2012
Portfolio Holdings for BVF
BVF holds 26 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals | 16.3 | $66M | 7.1M | 9.30 | |
| Nektar Therapeutics | 14.8 | $60M | 7.4M | 8.07 | |
| Ligand Pharmaceuticals In (LGND) | 14.6 | $59M | 3.5M | 16.94 | |
| Chemocentryx | 8.4 | $34M | 2.3M | 15.00 | |
| Ironwood Pharmaceuticals (IRWD) | 7.6 | $31M | 2.2M | 13.78 | |
| Array BioPharma | 7.1 | $29M | 8.2M | 3.47 | |
| ISIS Pharmaceuticals | 6.4 | $26M | 2.2M | 12.00 | |
| Qlt | 4.0 | $16M | 2.1M | 7.62 | |
| Endocyte | 3.8 | $15M | 1.9M | 8.22 | |
| Pain Therapeutics | 3.1 | $12M | 2.6M | 4.69 | |
| Oncothyreon | 2.7 | $11M | 2.3M | 4.68 | |
| Targacept | 2.4 | $9.5M | 2.2M | 4.30 | |
| A.P. Pharma (APPA) | 2.2 | $9.0M | 13M | 0.68 | |
| Cytokinetics | 1.5 | $5.9M | 9.2M | 0.64 | |
| Myrexis (MYRX) | 1.0 | $4.1M | 1.6M | 2.61 | |
| Genvec | 0.7 | $2.8M | 1.2M | 2.38 | |
| Flamel Technologies | 0.7 | $2.8M | 643k | 4.35 | |
| Palatin Technologies | 0.7 | $2.6M | 5.2M | 0.50 | |
| Vanda Pharmaceuticals (VNDA) | 0.5 | $2.0M | 460k | 4.40 | |
| DURECT Corporation | 0.5 | $1.9M | 2.1M | 0.91 | |
| ArQule | 0.3 | $1.4M | 229k | 5.93 | |
| Capstone Therapeutics | 0.3 | $1.2M | 7.8M | 0.16 | |
| Transcept Pharmaceuticals | 0.2 | $930k | 150k | 6.20 | |
| NeurogesX | 0.1 | $359k | 1.2M | 0.30 | |
| Cadus Corporation | 0.1 | $369k | 269k | 1.37 | |
| AutoImmune (AIMM) | 0.0 | $0 | 3.6M | 0.00 |
